The Danish company’s drugs for obesity could have a profound impact on healthcare, society and our relationship with food
FT Person of the Year: Lars Fruergaard Jørgensen of Novo Nordisk
Recent Posts
- US carries out second day of strikes against Iran
- New York’s socialist insurgency raises alarm among anxious Democrats
- Tower crash calls Beijing’s air security into question
- German carmakers embark on historic job cuts as Chinese rivals flood market
- Trump administration allows some access to Anthropic’s Mythos
